Description
Retatrutide (GLP-1/GIP/GCGR) 10mg is a synthetic triple receptor agonist studied in preclinical and clinical research for its interactions with GLP-1, GIP, and glucagon receptor binding and incretin/glucagon signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
Retatrutide has been investigated in peer-reviewed studies examining simultaneous activation of GLP-1R, GIPR, and GCGR receptors and associated neuroendocrine signaling mechanisms. References are provided for informational purposes relating to published scientific literature.
Product Specifications
- Molecular Formula: C₂₆₅H₄₄₀N₆₄O₈₁ (retatrutide)
- Purity: 99%+ verified by LCMS
- Format: Lyophilized powder
- Storage: -20°C, protected from light
- CAS Number: 2381296-47-3
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.
Research Resources
For research purposes only. Not for human use.

















